Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-722-6 | CAS number: 7704-34-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, unpublished report available, no restrictions, fully adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- other: Magnusson and Kligman test
- Justification for non-LLNA method:
- The first-choice method according to REACH Annex VII §8.3, the Murine Local Lymph Node Assay, is known to give false positive results with hydrocarbon substances.
Test material
- Reference substance name:
- Sulfur
- EC Number:
- 231-722-6
- EC Name:
- Sulfur
- Cas Number:
- 7704-34-9
- Molecular formula:
- S
- IUPAC Name:
- sulfur
- Details on test material:
- Test substance/item: sulphur 80% wg
Common name (active ingredient): sulfur
Name to be used in the report: sulphur 80% wg
Chemical name (IUPAC): sulfur
CAS no.: 7704-34-9
Batch no.: SML/RD/F/S-911
Manufactured and supplied by: Sulphur Mills Limited, Mumbai, India
Purity to be stated in the report: Min 80.00% w/w
Density: before compaction: 0.82 g/ml
after compaction: 0.86 g/ml
Physical appearance: brown coloured granules
Storage conditions: Ambient (+18 to +36 °C)
Analysed purity: 78.79% w/w
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Albino, NIH (Hartley)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Sri Venkateshwara Enterprises; Subramanyanagar; Bangalore - 560 021
- Age at study initiation: 8 weeks
- Weight at study initiation: males 305-360 g and females 273-382 g
- Housing: individually in suspended polypropylene bottom mesh cages (size approx. L 410 x B 28 x H 140 mm) with stainless steel top grill
- Diet (e.g. ad libitum): guinea pig feed manufactured by Nav Maharashtra Chakan Oil Mills Ltd., Pune-30, Maharashtra, India ad libitum
- Water (e.g. ad libitum): deep bore-well water passed through activated charcoal filter and exposed to UV rays. Vitamin C was supplemented in drinking water ad libitum.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23°C
- Humidity (%): 30-70%
- Air changes (per hr): 12-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: intradermal: saline or saline/FCA; epicutaneous: unchanged
- Concentration / amount:
- intradermal injection (induction): 1.0% w/v in normal saline
topical application (induction and challenge): 0.5 g test item as paste in de-ionised water (completely applied to induction site)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: intradermal: saline or saline/FCA; epicutaneous: unchanged
- Concentration / amount:
- intradermal injection (induction): 1.0% w/v in normal saline
topical application (induction and challenge): 0.5 g test item as paste in de-ionised water (completely applied to induction site)
- No. of animals per dose:
- control group: 5 males and 5 females
treatment group: 10 males and 10 females - Details on study design:
- 1. IRRITANCY TESTING
Intradermal irritancy test: sulfur at concentrations of 1%, 2.5% and 5% w/v in normal saline was injected intradermally (0.1 ml, in duplicate) into the clipped shoulder region of 2 guinea pigs. Erythema and oedema (grade 1) present at 24 hr and 48 hr at all sites. 1% w/v in saline was selected as the concentration for intradermal induction.
Topical irritancy test: sulfur at concentrations of 25%, 50% and 75% w/v in acetone was applied topically (0.1 ml, in duplicate) under patches (see below) to the clipped flanks of 4 guinea pigs. The only reaction observed was very slight erythema (grade 1) in 1 animal exposed to 75% sulfur. Given the absence of dermal responses seen, 0.5 g sulfur as a paste in de-ionised water was selected for topical induction and challenge.
2. INTRADERMAL INJECTION
The hair of all the animals in the control (G1) and treatment (G2) groups was removed from the shoulder region (at least an area of 2 x 4 cm) using an electric clipper, approximately 24 hours before administration.
Day 1. The animals were injected using sterile 1 ml tubercuIin syringe fitted with 26 gauge needle at the shoulder region with 0.1 ml each of 3 pairs of intradermal injections so that one injection of each pair on either side of the midline. Injections 1 and 2 were given near the head region 1 cm apart and injection 3 towards caudal part of the body.
CONTROL GROUP (G1);
1) Two 0.1 ml injections of 1:1 mixture (v/v) FCA in normal saline at site marked '1' (Solution 1).
2) Two 0 1 ml injections of the undiluted vehicle (normal saline) at site marked '2'
3) Two 0.1 ml injections of 1:1 mixture of vehicle and solution 1 at sites marked '3'
Injections 1 and 2 were given near to each other (1 cm apart) while Injection 3 was given slighty away from site 2 (about 2 cm apart).
TREATMENT GROUP (G2)
1) Two 0.1 ml injections of 1:1 mixture (vlv) of Freunds Complete Adjuvant (FCA) in normal saline at sites marked '1',
2) Two 0.1 ml injections of test item in vehicle (normal saline) at concentration of 1%w/v at sites marked '2',
3) Two 0.1 ml injections of test item in vehicle mixed 1:1 with 1:1 mixture (v/v) of FCA and normal saline at sites marked 3, such that the final concentration of test item injected is the same as that it site 2. Injections 1 and 2 were given near to each other (1 cm apart) while injection 3 was given slightly away from 2 (about 2 cm apart).
3. INDUCTION (BOOSTING) TOPICAL APPL ICATION
On day 7, the intradermal injection site (approximately 2 x 4 cm area) was closely clipped and the test area was painted with 0.5 ml of 10% w/v sodium lauryl sulphate in liquid paraffin to produce local irritation (since the test item did not cause skin irritation during pre-study). Approximately 24 hours after clipping on day 8, 0.5 g of test item as paste in de-ionised water was transferred completely on to the filter paper (2 x 4 cm) and applied on to the skin (site of intradermal injection) and covered with cotton gauze (size 3 x 4 cm - 6 ply).
This was held in place for 48 hours by adhesive tape (for occlusion) and crepe bandage wound around torso over which a clean cotton cloth (many tailed bandage) was tied to anchor the crepe bandage.
Control group: Handled similar to treatment group animals but the control patch was applied (fully loaded filter paper with de-ionised water).
4. CHALLENGE
TOPICAL APPLICATION
The treatment group and vehicle central group animals were challenged on the 22nd day of the test (the day of intradermal injections to animals is reckoned as day '1' of the test), by topical application of test item to control and the treatment group animals (at its highest non-irritant dose as determined by the pre-study). One male and two female guinea pigs of the vehicle control group were not challenged and retained naive.
i) One day before the challenge application, on day 21, the hair on both the flanks (approximately 80 sq cm- 8 x 10 cm ) was closely clipped.
ii) On day 22. 0.5 g of test item as a paste in deionised water was transferred completely onto the filter paper (size: 2 x 4 cm) and applied on to the left flank of the skin and covered with cotton gauze (size 3 x 4 cm - 6 ply).
Similarly, filter paper strip (2 x 4 cm) fully leaded with de-ionised water was applied on to the right flank and covered by 3 x 4 cm cotton gauze of 6 ply. The patches were held in place with the help of adhesive tape and crepe bandage wound around torso over which a clean cotton cloth (many tailed bandage) was tied to anchor the crepe bandage.
These challenge patches were kept in contact with the skin for a period of 24 hours. On the 23rd day, the patches were removed and the area of skin where the test patch was applied was cleaned with normal saline swabs.
iii) 24 hours after the removal of patches (viz 48 hours after challenge application), the skin was examined for skin reactions, which was scored using Draize criteria.
Skin was observed again at 48 hours after the removal of the test patch or on day 25 (72 hours after the challenge application) in order to confirm the previous days observations. All the observations were recorded. - Positive control substance(s):
- yes
- Remarks:
- historical data (2-mercaptobenzothiazole)
Results and discussion
- Positive control results:
- Challenge application: 8 out of 10 guinea pigs had score of 1 (discrete or patchy erythema) at 24 hours and 7 out of 10 guinea pigs had score of 1 (discrete or patchy erythema) at 48 hours post removal of the test patch.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no dermal responses present
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no dermal responses present.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no dermal responses present
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no dermal responses present.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses present
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses present.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses present
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses present.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 2-Mercaptobenzothiazole
- No. with + reactions:
- 10
- Total no. in group:
- 10
Any other information on results incl. tables
Intradermal injection
At 24 hours (post administration) observation period erythema (score value of 1 - very slight erythema {barely perceptible}} and edema (score value of 1 - very slight edema {barely perceptible}) were observed in all the animals at sites 1, 2 and 3 which persisted through 48 hours at sites 1 and 3. However at site 2 erythema was observed in 7 and edema was observed in 6 out of 20 animals at 48 hours observation.
Topical boosting
There were no skin reactions at 1 and 24 haws post removal of the test patch.
Challenge
There were no skin reactions at 24 and 48 hours post removal of the test patch.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Sulfur was not a sensitizer under the conditions of the test.
- Executive summary:
The sensitization potential of sulfur was evaluated in a GLP compliant guinea pig maximization study following OECD guideline 406. Following an irritancy screen, 1% w/v in normal saline was selected for intradermal induction and 0.5 g sulfur (as a paste in de-ionised water, applied under occlusive conditions) selected for topical induction and challenge. 2-Mercaptobenzothiazole was used as a positive control substance, and dermal responses were evaluated in all groups using Draize criteria. No erythema or oedema was present in either the control or test groups 24 hr or 48 hr post- challenge, however a satisfactory response was obtained in the positive control group.
It was concluded that sulfur was not a sensitizer under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)